News | September 15, 2010

Ultrasound Breast Cancer Screening Gains Approval in EU

September 15, 2010 — Approval has been given to market the somo•v automated breast ultrasound system (ABUS) as an adjunct to mammography for screening asymptomatic women for breast cancer in the European Union. Approval was based on extensive clinical evidence and includes the following indication: “The intended use of the somo•v ABUS system is to provide a significant increase in breast cancer detection and sensitivity of interpreting physicians in diagnosing symptomatic and screening asymptomatic women as an adjunct to mammography.”

U-Systems' somo•v ABUS now has CE mark approval for breast cancer screening and is the first and only approved automated ultrasound system for screening asymptomatic women. The company notes that several studies have demonstrated a need for additional tools to improve the early detection of breast cancer, particularly in women with dense breast tissue.

“The somo•v ABUS is not intended as a replacement for mammography, which remains the most effective screening tool for many women," said Ron Ho, president and CEO of U-Systems. "However, we have strong scientific evidence that for women with dense breast tissue, supplementing mammograms with somo•v ABUS can substantially increase breast cancer detection.”

“The sensitivity of screening mammography is limited in women with dense breasts, as low as 30-50%,” said László Tabár, M.D., FACR (Hon) professor of radiology, Uppsala University School of Medicine, and Medical Director at the Department of Mammography Falun Central Hospital, Falun, Sweden. “It is essential to have a multimodality screening approach for detecting breast cancer at an early stage to prevent women from dying from this disease. The somo•v automated breast ultrasound system fulfills this important need in the multimodality approach.”

U-Systems is currently sponsoring the SOMO•INSIGHT clinical study, designed to evaluate whether digital mammography in combination with the somo•v system is more sensitive than a routine screening mammogram alone in detecting breast cancer in women with greater than 50 percent dense breast tissue. To date, more than 9,000 women have participated in the study, which is actively recruiting up to 20,000 women at multiple breast imaging centers in the United States.

The SOMO·INSIGHT clinical study has identified a significant number of mammographically negative breast cancers that would not have been detected had the participants not had an ABUS exam.

For more information: www.somoinsightstudy.org

Related Content

Technology | Ultrasound Imaging | August 18, 2017
August 18, 2017 — SuperSonic Imagine recently introduced the newest version of its premium...
Pentax Medical Launches New Slim Linear Ultrasound Endoscope
Technology | Endoscopes | August 17, 2017
Pentax Medical Co. announced the U.S. launch of the Slim Linear Ultrasound Endoscope (EG-3270UK), the company's newest...
Houston Methodist Hospital Enters Multi-Year Technology and Research Agreement With Siemens Healthineers
News | Imaging | August 17, 2017
Houston Methodist Hospital and Siemens Healthineers have entered into a multi-year agreement to bring cutting-edge...
Patient Complexity, Subspecialization Impact List Prices for Radiologists' Services
News | Business | August 15, 2017
A new study by the Harvey L. Neiman Health Policy Institute finds that patient condition complexity and...
Upcoming radiology conferences, meetings and events.
News | August 14, 2017
ITN maintains a comprehensive listing of radiology specialty meetings on its website at ...
Clarius Wireless Ultrasound Scanners Now Available With Advanced Features
News | Ultrasound Imaging | August 09, 2017
Clarius Mobile Health has released advanced features and options for its wireless handheld ultrasound scanner for...
MRI Reveals Striking Brain Differences in People with Genetic Autism

Example images for a control participant , a deletion carrier, and a duplication carrier. In the sagittal image of the deletion carrier, the thick corpus callosum, dens and craniocervical abnormality, and cerebellar ectopia are shown. For the duplication carrier, the sagittal image shows the thin corpus callosum and the axial image shows the increased ventricle size and decreased white matter volume. Image courtesy of the Radiological Society of North America (RSNA).

News | Neuro Imaging | August 09, 2017
August 9, 2017 — In the first major study of its kind, researchers using magnetic...
ACR Establishes Education Committee for Patient- and Family-Centered Care
News | Patient Engagement | August 09, 2017
Members of the new Education Committee of the American College of Radiology (ACR) Commission on Patient- and Family-...
ACR Annual Conference on Quality and Safety Offers Strategies for Radiology Practices
News | Business | August 08, 2017
The American College of Radiology (ACR) Annual Conference on Quality and Safety, scheduled for Oct. 13-14 in Boston,...
Overlay Init